IgM Nephropathy in Older Patients: Severe Steroid Myopathy Prompting Rituximab Rescue in an Understudied Entity (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0700; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Prednisone 60 mg daily was started and UPCR improved to 2.7 g/g. IgMN compounds the difficulty because it is poorly characterized, often steroid-dependent or steroid-resistant, and lacks a consensus treatment protocol. While data for rituximab in IgMN remain sparse and largely pediatric, this case suggests that earlier transition to rituximab in elderly patients at high risk of steroid toxicity may prevent significant treatment-related morbidity."
Clinical • Acute Kidney Injury • Atherosclerosis • Cardiovascular • Chronic Kidney Disease • Diabetes • Diabetic Nephropathy • Focal Segmental Glomerulosclerosis • Gastroenterology • Geriatric Disorders • Glomerulonephritis • Hepatology • Human Immunodeficiency Virus • Hypertension • Infectious Disease • Inflammation • Metabolic Disorders • Myositis • Nephrology • Renal Disease • Type 2 Diabetes Mellitus
|
|
Amit Kaushal; Brett Anthony Miller; Ujjwala Murari; Ojaswi Singh Tomar; Sheikh Raza Shahzad
|